KIDS Orthopediatrics Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: KIDS

Price (delayed)

$30.43

Market cap

$794.54M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.43

Enterprise value

$879.8M

?
Relative Growth: Rel. Growth: 69
Relative Strength: Rel. Strength: 96
Relative Valuation: Rel. Valuation: 16
Relative Profitability: Rel. Profitability: 41

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. ...

Highlights
The EPS is up by 27% year-on-year and by 15% since the previous quarter
The net income has grown by 26% YoY and by 15% from the previous quarter
The quick ratio has contracted by 44% YoY and by 9% from the previous quarter
The equity has declined by 2.9% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.orthopediatrics.com
Peers: OFIX

Key stats

What are the main financial stats of KIDS

KIDS stock price

How has the Orthopediatrics stock price performed over time
Intraday
-1.43%
1 week
26.69%
1 month
37.32%
1 year
80.7%
YTD
71.34%
QTD
36.64%

Financial performance

How have Orthopediatrics's revenue and profit performed over time
Revenue
$264.14M
Gross profit
$194.84M
Operating income
-$24.8M
Net income
-$33.88M
Gross margin
73.8%
Net margin
-12.8%
KIDS's operating margin has surged by 53% year-on-year and by 21% since the previous quarter
Orthopediatrics's operating income has increased by 45% YoY and by 17% QoQ
KIDS's net margin is up by 36% year-on-year and by 18% since the previous quarter
The net income has grown by 26% YoY and by 15% from the previous quarter

Price vs fundamentals

How does KIDS's price correlate with its fundamentals

Growth

What is Orthopediatrics's growth rate over time

Valuation

What is Orthopediatrics stock price valuation
P/E
N/A
P/B
2.34
P/S
2.78
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.33
The EPS is up by 27% year-on-year and by 15% since the previous quarter
The price to book (P/B) is 67% more than the last 4 quarters average of 1.4
The equity has declined by 2.9% year-on-year
KIDS's price to sales (P/S) is 54% higher than its last 4 quarters average of 1.8 but 43% lower than its 5-year quarterly average of 4.9
The revenue rose by 16% year-on-year and by 4.5% since the previous quarter

Efficiency

How efficient is Orthopediatrics business performance
The return on sales is up by 48% year-on-year and by 25% since the previous quarter
KIDS's ROIC is up by 45% YoY and by 21% from the previous quarter
The return on assets is up by 29% year-on-year and by 15% since the previous quarter
Orthopediatrics's ROE has increased by 24% YoY and by 14% from the previous quarter

Dividends

What is KIDS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KIDS.

Financial health

How did Orthopediatrics financials performed over time
Orthopediatrics's total assets is 200% more than its total liabilities
The quick ratio has contracted by 44% YoY and by 9% from the previous quarter
Orthopediatrics's current ratio has decreased by 39% YoY and by 4.8% QoQ
KIDS's debt is 70% smaller than its equity
The equity has declined by 2.9% year-on-year
The debt to equity has grown by 3.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.